𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Crystal Structures of Actinomycin D and Actinomycin Z3

✍ Scribed by Martina Schäfer; George M. Sheldrick; Isabel Bahner; Helmut Lackner

Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
164 KB
Volume
37
Category
Article
ISSN
0044-8249

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Actinomycin-D, levamisole chemoimmunothe
Actinomycin-D, levamisole chemoimmunotherapy of refractory malignant melanoma
✍ Stephen W. Hall; Robert S. Benjamin; Uri Lewinski; Giora Mavligit 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 433 KB

Sixty adult patients with disseminated melanoma refractory to DTIC or Dacarbazine were given chemoimmunotherapy with intermittent high single dose Actinomycin-D and Levamisole. Actinomycin-D was given at a dose of 1.5-2.0 mg/m\* intravenously every 3 to 4 weeks. Levamisole was given in a dose of 150

Actinomycin D induces apoptosis and inhi
Actinomycin D induces apoptosis and inhibits growth of pancreatic cancer cells
✍ Jörg Kleeff; Marko Kornmann; Harneet Sawhney; Murray Korc 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 366 KB

Pancreatic cancer cells are usually resistant to apoptosis induced by cytotoxic drugs, by activation of surface receptors such as Fas and TNF receptor or by serum or growth factor withdrawal. Actinomycin D (actD) is an inhibitor of RNA synthesis and acts as a potent inducer of apoptosis in several c

Combined actinomycin D and vincristine i
Combined actinomycin D and vincristine in the treatment of patients with cancer
✍ Raul E. Chanes; Paul T. Condit; Richard H. Bottomley; William Nisimblat 📂 Article 📅 1971 🏛 John Wiley and Sons 🌐 English ⚖ 313 KB 👁 1 views

A combination of actinomycin D and vincristine has been used to treat 92 patients with various kinds of cancer. The best results were obtained in patients with lung cancer, with a n initial response rate of 6096 and an average duration of remission of over 8 months. Some patients with sarcomas and m